An increase in galectin-3 identifies males at risk of new-onset HF and new-onset cancer
This video was recorded during the ESC Heart Failure Congress 2022 in Madrid, Spain.
Freek van den Berg, MD, is a PhD candidate at the University Medical Center Groningen in The Netherlands.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.